KIE State Street SPDR S&P Insurance ETF
Profitability Metrics
Valuation Metrics
Growth & Cash Flow
Price Change
Top 10 Holdings
| Stock Ticker | Weight |
|---|---|
| SPNT | 2.02% |
| BWIN | 1.99% |
| OSCR | 1.95% |
| LMND | 1.95% |
| KMPR | 1.93% |
| LNC | 1.93% |
| PLMR | 1.92% |
| UNM | 1.92% |
| CNO | 1.92% |
| PFG | 1.91% |
ETF Analysis
Fund Overview
State Street SPDR S&P Insurance ETF (KIE) currently reports 54 stock positions (subject to change), placing it in the selectively diversified range by holdings breadth. The top line-up is SPNT (2.02%), BWIN (1.99%), OSCR (1.95%), with SPNT as the largest single weight at 2.02%. Together, the top three holdings account for 5.96%, which points to a relatively flat weight distribution where no single cluster of names dominates outcomes. The weight distribution suggests a portfolio designed to capture thematic upside while avoiding excessive dependence on any single name outside the largest positions.
Profitability & Capital Efficiency
Assessing the quality of returns on invested capital, ROIC is 11.90%, WACC is 7.24%, and the economic spread is 4.66%. On balance, the economic spread is thin but positive — the portfolio's businesses are clearing the hurdle, though without significant headroom. Supporting metrics show ROE at 14.65% and ROA at 3.32%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a portfolio that is value-creative but with less room for execution slippage.
Valuation
The portfolio's current market valuation reflects trailing P/E of 11.81, forward P/E of 10.44, PEG of 1.98. The trailing-to-forward compression is minimal, consistent with a market that sees limited earnings acceleration from current levels. The PEG reads as moderate — investors are paying a fair but not discounted price for the growth embedded in current estimates. The current ratio of 1.72 is in an acceptable range, reflecting reasonable short-term financial health. Across multiples and liquidity, the portfolio is priced in a way that reflects current expectations reasonably well — leaving limited room for error, but also limited near-term downside from valuation compression alone.
Margins & Cash Generation
Looking at margins from gross to free cash flow, gross margin sits at 35.85%, operating margin at 17.00%, and free cash flow margin at 20.66%. The gross margin reading is middling — acceptable, but leaving less room for error at the production level. At this level, operating margins reflect businesses that are scaling with discipline without dramatic cost pressure. The portfolio's cash conversion is solid — a sign that operating profits are translating into real liquidity at the fund level. Together, these margins describe a portfolio where business quality varies — and where macro or sector headwinds could disproportionately impact the weaker-margin holdings.
Growth & Forward Outlook
Projected 12-month EPS growth of 13.1% is a constructive signal — measured earnings expansion supports the forward valuation case without relying on aggressive extrapolation. Zooming out from the valuation discussion, TTM revenue growth of 21.04% pointing to sustained and broad-based revenue growth within the basket, while the estimated 12-month price change of 17.04%, where target prices point to mid-range appreciation potential from current levels. Anchoring to reported revenues provides discipline; analyst price targets add context about how the market currently values that operating reality. The path to realizing analyst-implied returns runs through revenue execution, margin stability, and a macro environment that doesn't undermine either. The estimated 12-month price change is a weighted composite of analyst price target estimates adjusted by each holding's ETF weight, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.
Conclusion
BuyTaken together, the metrics present a favorable setup — not without risk, but with enough quality and momentum to support a positive view.
This assessment reflects quantitative metrics only and does not constitute financial advice or a recommendation to buy or sell any security. Past performance is not indicative of future results.